GRAIL, Inc.
General ticker "GRAL" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $2.2B (TTM average)
GRAIL, Inc. follows the US Stock Market performance with the rate: 39.5%.
Estimated limits based on current volatility of 3.8%: low 60.87$, high 65.67$
Factors to consider:
- Total employees count: 175000 as of 2024
- North and South America accounted for 86.4% of revenue in the fiscal year ended 2024-12-31
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [42.61$, 104.44$]
- 2026-12-31 to 2027-12-31 estimated range: [23.77$, 63.92$]
Short-term GRAL quotes
Long-term GRAL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $93.11MM | $125.59MM | $147.17MM |
| Operating Expenses | $1,608.49MM | $2,314.75MM | $709.34MM |
| Operating Income | $-1,515.38MM | $-2,189.16MM | $-562.16MM |
| Non-Operating Income | $7.75MM | $26.80MM | $27.66MM |
| R&D Expense | $338.75MM | $322.38MM | $195.79MM |
| Income(Loss) | $-1,507.64MM | $-2,162.36MM | $-534.50MM |
| Taxes | $-41.95MM | $-135.36MM | $-126.15MM |
| Profit(Loss)* | $-1,465.68MM | $-2,027.01MM | $-408.35MM |
| Stockholders Equity | $0.00MM | $2,503.41MM | $2,577.86MM |
| Inventory | $21.70MM | $18.63MM | $16.02MM |
| Assets | $3,913.81MM | $2,983.31MM | $2,922.01MM |
| Operating Cash Flow | $-595.80MM | $-577.16MM | $-299.01MM |
| Capital expenditure | $12.89MM | $5.21MM | $0.91MM |
| Investing Cash Flow | $-12.89MM | $-551.01MM | $-85.05MM |
| Financing Cash Flow | $463.77MM | $1,244.30MM | $423.32MM |
| Earnings Per Share** | $-47.20 | $-63.54 | $-11.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.